Showing results (271-280 of 920) with videos related to
Sort By:
Pageof 92
Catheterization and Cardiovascular Diagnosis|January 1, 1987
Anticoagulation with heparin during cardiac catheterization and its reversal by protamineG J Dehmer, D Haagen, C R Malloy, et al.Journal of Addiction Medicine|August 14, 2023
Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series StudyLuba Yammine, Jessica C Balderas, Michael F Weaver, et al.Resuscitation|June 1, 1987
Fluid loading with whole blood or Ringer's lactate solution during CPR in dogsW D Voorhees, S H Ralston, C Kougias, et al.Breast Cancer Research and Treatment|June 1, 1995
Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: immune phenomena or drug toxicity?G J Locker, I Simonitsch, R M Mader, et al.Anti-Cancer Drugs|April 6, 2001
Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patientsG J Locker, C Wenzel, M Schmidinger, et al.International Journal of Cancer|September 8, 2004
Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profilingWolfgang M Schmidt, Maria Kalipciyan, Eva Dornstauder, et al.Oncology|March 1, 1995
New mucin-like cancer-associated antigens (CA M 26, CA M 29 and CA 549) and a new proliferation marker (TPS) in patients with primary or advanced breast cancerG J Locker, R M Mader, J Braun, et al.British Journal of Clinical Pharmacology|March 1, 1994
Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancerR M Mader, G G Steger, B Rizovski, et al.Plos One|August 22, 2014
Indocyanine green video angiography predicts outcome of extravasation injuriesWerner Haslik, Ursula Pluschnig, Günther G Steger, et al.Wiener Klinische Wochenschrift|May 29, 1987
[Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas]K Heimberger, P Samec, I Podreka, et al.Pageof 92